William John Sibold, President and CEO: Madrigal Pharmaceuticals MDGL Planned sale · Filed 07/20

Trade details

Type: Planned sale notice
Stock: Madrigal Pharmaceuticals MDGL
Person: William John SiboldPresident and CEO
Planned sale date: 26/07/20
Filed: 26/07/20

$1.4M to be sold

Madrigal Pharmaceuticals trades, last 26 weeks

What else happened in Madrigal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 06/20~08/19

William John Sibold's recent trades

William John SiboldPresident and CEO
Planned sale10b5-1 planMadrigal Pharmaceuticals
Planned sale10b5-1 plan
Madrigal Pharmaceuticals
MDGL
$2.8M
5,221 sh
$2.8M
Filed 09/11
Traded 09/11
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$3.4M
6,362 sh
$3.4M
Filed 09/09
Traded 09/09
William John SiboldPresident and CEO
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$718.3K
1,663 sh
$718.3K
Filed 03/06
Traded 03/06
William John SiboldPresident and CEO
Planned saleMadrigal Pharmaceuticals
Planned sale
Madrigal Pharmaceuticals
MDGL
$730.6K
1,663 sh
$730.6K
Filed 03/06
Traded 03/06
William John SiboldPresident and CEO
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$776.5K
1,577 sh
$776.5K
Filed 01/26
Traded 01/26

William John Sibold, CEO — plans to sell 2,500 sh of Madrigal Pharmaceuticals MDGL · $1.4M · around 07/20 | Whalegun